Spotlight On ATTR-CM
Welcome to Spotlight On ATTR-CM, your go-to source for the latest research, diagnostic advancements, and therapeutic strategies in transthyretin amyloid cardiomyopathy (ATTR-CM). Join leading cardiologists and researchers as they share their insights on this intricate condition to enhance patient care and outcomes.
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Heart MattersRecognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Exploring Deeper Silencing in Transthyretin Amyloidosis
AudioAbstractsExploring Deeper Silencing in Transthyretin Amyloidosis
Ryan Quigley
How Symptoms Shape Caregiver Burden in ATTR-CM
AudioAbstractsHow Symptoms Shape Caregiver Burden in ATTR-CM
Ryan Quigley
Ronald Witteles, MD
The Limits of Traditional AFib Prediction Models in ATTR-CA
Heart MattersThe Limits of Traditional AFib Prediction Models in ATTR-CA
Quality of Life Conversations in ATTR-CM Care
Heart MattersQuality of Life Conversations in ATTR-CM Care
Kevin S. Shah, MD
Supporting Patients With ATTR-CM: Preserving Function and Quality of Life
Heart MattersSupporting Patients With ATTR-CM: Preserving Function and Quality of Life
Joban Vaishnav, MD
Counseling Patients on Disease Progression in ATTR-CM
Heart MattersCounseling Patients on Disease Progression in ATTR-CM
Joban Vaishnav, MD
Rethinking Thromboembolic Risk in ATTR-CM Care
Heart MattersRethinking Thromboembolic Risk in ATTR-CM Care
Silencers and Stabilizers in ATTR-CM: Challenging Assumptions
Heart MattersSilencers and Stabilizers in ATTR-CM: Challenging Assumptions
Heart Failure Hospitalization and Mortality in Cardiac Amyloidosis
Heart MattersHeart Failure Hospitalization and Mortality in Cardiac Amyloidosis
- advertisement
Differential Diagnosis in ATTR-CM: 99mTc-PYP Scintigraphy and Diagnostic Workup
Spotlight On ATTR-CMDifferential Diagnosis in ATTR-CM: 99mTc-PYP Scintigraphy and Diagnostic Workup
Refractory Disease in ATTR-CM: Tafamidis and Treatment Decisions
Spotlight On ATTR-CMRefractory Disease in ATTR-CM: Tafamidis and Treatment Decisions
- advertisement